USPTO serial 88162353
PHARMASEEK
Reviewed by CopyMark Law Group
Reg. 5906688Status 710
- Filing date
- Status date
- Registration date
- Nov 12, 2019
- Examiner
- MUNSON OTT, MARY DEIRDRE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PHARMASEEK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Madison, WI, US
Madison, WI, US
Madison, WI, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica L. Rothstein
Jessica L. Rothstein Goodwin Procter LLP620 Eighth AvenueNew York, NY 10018UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting, management, and planning services in the field of clinical trials, namely, analyzing and reporting possible cost savings in human research study protocol development and possible cost savings in research site identification on behalf of pharmaceutical trial sponsors and contract research organizations, all for business cost management purposes; Business consulting, management, and planning services in the field of clinical trials, namely, applying business analytics to determine the appropriate payer coverage and negotiate study budgets for clinical trial sites; Business consulting in the field of clinical trial study identification on behalf of clinical trial sites; Business consulting in the field of clinical trials, namely, negotiating clinical trial budgets and business contracts on behalf of clinical trial sites; Administration, billing and reconciliation of accounts for clinical trial sites | SECTION 8 - CANCELLED | Dec 31, 2002 |
| 036 | Bill payment services; Accounts receivables financing; Financial management of reimbursement payment for clinical trial sites; and Financial management in the field of clinical trials, including accounts receivable financing and accounts payable debiting, for clinical trial sites | SECTION 8 - CANCELLED | Dec 31, 2002 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 22, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 12, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 9, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 9, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 22, 2020 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 12, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 11, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 28, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 27, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 27, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 7, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 21, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 11, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 11, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 29, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 29, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 29, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 1, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2018 | NWAP | NEW APPLICATION ENTERED | — |